This content is from: Patents

UK Supreme Court’s Actavis ruling finds balance for pharma and generics: lawyers

The UK Supreme Court’s ruling in Actavis v Icos is likely to satisfy pharmaceutical and generics companies, according to lawyers involved in the case

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial